Becton, Dickinson and Company (BD) has partnered with Mayo Clinic to gain access to de-identified patient data from Mayo Clinic Platform_Discover, as reported by a press release dated June 13, 2022. The platform includes data sets from 10 million patients. BD announced that the company intends to utilize this real-world patient data to enhance existing products and address unmet needs.
The Mayo Clinic Platform website describes the platform as a “suite of products enable customers to develop and deploy health care solutions quicker, with higher quality and lower cost.”
BD said the historical database includes both structured and unstructured data, images, 1.2 billion lab test results, 3 million echocardiograms and more than 640 million clinical notes. It plans to use this to understand device use, increase clinical trial efficiency, and streamline medical device regulatory submissions (supplementing data from randomized control trials).
Mayo Clinic has previously announced partnerships with nference in connection with the Mayo Clinic Platform in 2021 and, separately, with Google in connection with AI-enabled digital diagnostics in 2019.
